Status:
RECRUITING
Comparison Between Interleukin 6 and Procalcitonin in Detecting Sepsis and Incidence of Mortality in Burn ICU Patients
Lead Sponsor:
Ain Shams University
Conditions:
Burns
Sepsis
Eligibility:
All Genders
25-60 years
Phase:
NA
Brief Summary
The investigators will compare the efficacy of Interleukin-6 (IL-6) as a better indicator than procalcitonin in burn patients with sepsis or septic shock regarding success of treatment and early ICU d...
Detailed Description
Interleukin 6 and procalcitonin will be sampled for all patients on days 1, 3, 7, and 10. Treatment plan will be initiated to all patients according to the burn ICU protocol. According to the lab re...
Eligibility Criteria
Inclusion
- Patients with acute burn admitted to burn ICU within 24 hours from the burn incidence.
- patients with burn percentage of 25% to 50% of total body surface area
- patients with second to third degree burns
- ASA 1 and ASA 2 patients
Exclusion
- Burn percentage more than 50% or less than 25% of total body surface area
- Having autoimmune diseases
- Cancer patients
- ASA 3 and ASA 4 patients
Key Trial Info
Start Date :
January 10 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 10 2025
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT06915974
Start Date
January 10 2025
End Date
July 10 2025
Last Update
April 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ain Shams University
Cairo, Egypt